IL17A and arthritic joint disease: Furthermore, because mast cells can produce many other cytokines as well, blocking the activation of mast cells, such as by preventing their activation via the FcεRI through anti-IgE treatment, might lead to even more profound effects than blocking IL-17 alone in arthritis patients.